Beijing Increasepharm Corporation Limited (Increasepharm), started since 1999, headquartered in Zhongke Yungu Park, Changping District, Beijing.

Founded in 2015, located in Building 24, No. 79 Shuangying West Road, Changping District, Beijing, with an experimental area of nearly 7,000 m².

公司主要进行各类新药I期、II期、III期、IV期临床试验、上市后再评价、中药保护品种临床试验、一致性评价、临床研究项目的第三方稽查、医疗器械临床研究、保健食品临床研究、特殊医学用途配方食品临床研究、技术咨询与服务（含专家咨询会议、申报资料撰写等）。

The functional laboratory meets the requirements of clinical examination, analysis, histopathology, cell biology, inhalation pharmacology & toxicology and other related index tests.

Increasepharm (Tianjin) Institute Co., Ltd. which was built in 2017, is a wholly-owned subsidiary of Beijing Increasepharm Corporation Limited.

Increase Innovation (Shanghai) Health Management Co., Ltd. was registered and established in Shanghai Pilot Free Trade Zone on November 28, 2019.

Increasepharm (Hengqin) Institute Co., Ltd. was established on January 4, 2017 and located in Zhuhai Hengqin New District, Guangdong-Macao Cooperation TCM Technology Industrial Park, where has an existing R&D office space of 1,200 square meters.

Increase (Zhuhai) Pharmaceutical Co., Ltd was registered in August 2017, the Biomedical Demonstration Zone of Jinwan District, Zhuhai.

Increasepharm (HK) Co., Ltd was established on October 30, 2018, as a subsidiary of Beijing Increasepharm Corporation Limited.